INOVIO's Participation in Upcoming Investor Conferences
INOVIO (NASDAQ: INO), a forefront biotechnology company, focuses on advancing DNA medicines aimed at addressing health issues such as HPV-related diseases, cancer, and infectious diseases. As part of its investor engagement strategy, the company has announced participation in several prominent investor conferences this December.
Piper Sandler 37th Annual Healthcare Conference
One of the key events on INOVIO's agenda is the Piper Sandler 37th Annual Healthcare Conference held in New York. Scheduled for December 2, this event will feature a fireside chat from 8:30 to 8:55 AM ET. Interested parties can access the live webcast, along with a replay for 90 days post-event. This presentation is an excellent opportunity for investors to gain insights into INOVIO’s strategies and innovations in the biopharmaceutical space.
Oppenheimer Movers in Rare Disease Summit
Another notable gathering is the Oppenheimer Movers in Rare Disease Summit taking place on December 11. Scheduled between 12:05 and 12:25 PM ET, this event will feature a panel discussing elevator pitches from rare disease companies, including INOVIO. This format enables attendees to deeply understand the company’s groundbreaking approaches in the challenging realm of rare diseases.
One-on-One Meetings with Investors
In addition to these conferences, INOVIO’s management team will host one-on-one meetings with investors to discuss the company's progress, pipeline, and future direction. This personalized interactions serve as a platform for investors to ask questions and engage with the leadership team directly, highlighting INOVIO's commitment to transparency and collaboration.
About INOVIO’s Innovative Approaches
INOVIO specializes in creating DNA medicines designed to empower the body to produce its own disease-fighting tools. This innovative approach leverages unique technology that focuses on teaching the immune system to combat diseases more effectively. Dedication to research and development at INOVIO positions the company continually at the forefront of biotechnology, allowing for the creation of solutions for pressing healthcare challenges.
Contacts for More Information
For media inquiries, individuals can reach out to Jennie Willson at (267) 429-8567. Investors looking for further information can connect with Peter Vozzo from ICR Healthcare at (443) 213-0505. Both representatives are available to provide insights and information on INOVIO’s initiatives and advancements.
Frequently Asked Questions
What is the primary focus of INOVIO?
INOVIO focuses on developing DNA medicines that target diseases such as HPV, cancer, and various infectious diseases.
When are the investor conferences taking place?
INOVIO will participate in the Piper Sandler Conference on December 2 and the Oppenheimer Summit on December 11.
How can investors engage with INOVIO’s management?
Investors can engage through one-on-one meetings scheduled during the conferences for more in-depth discussions.
What is the format of the Piper Sandler Conference presentation?
INOVIO's presentation at the Piper Sandler Conference will take the form of a fireside chat.
Who can I contact for media inquiries about INOVIO?
Media inquiries can be directed to Jennie Willson at (267) 429-8567.
